ProQR Therapeutics N.V. (PRQR)
1.41
-0.02 (-1.40%)
At close: Mar 28, 2025, 3:59 PM
1.43
1.46%
After-hours: Mar 28, 2025, 05:53 PM EDT
ProQR Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -27.76M | -27.54M | -64.89M | -61.68M | -46.61M | -56.75M | -37.09M | -43.52M | -39.12M | -20.83M | -12.13M | -3.25M |
| Depreciation & Amortization | 2.76M | 2.46M | 2.52M | 2.33M | 2.35M | 2.05M | 992K | 1.06M | 1.25M | 480K | 126K | 24K |
| Stock-Based Compensation | 2.54M | 3.11M | 2.87M | 6.22M | 7.84M | 9.11M | 3.22M | 4.02M | 2.45M | 1.21M | 646K | 41K |
| Other Working Capital | -13.26M | 48.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -474K | -5.35M | -3.67M | 2.01M | -5.75M | -402K | 792K | 3.17M | -470K | -6.17M | -4.33M | 14K |
| Deferred Income Tax | -197K | -78K | 96K | 117K | 124K | 235K | 102K | 145K | 236K | 441K | 142K | 13K |
| Change in Working Capital | -13.26M | 48.96M | -5.43M | 25M | -5.01M | 1.78M | 1.29M | 164K | 1.43M | 637K | 1.09M | 829K |
| Operating Cash Flow | -36.39M | 21.55M | -68.51M | -26.01M | -47.06M | -43.97M | -30.68M | -34.95M | -34.22M | -24.23M | -14.46M | -2.33M |
| Capital Expenditures | -1.42M | -1.37M | -708K | -484K | -924K | -580K | -312K | -121K | -2.54M | -1.32M | -1.23M | -137K |
| Acquisitions | n/a | 58.77K | 5.89K | 61.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -2.65M | 7.86M | 108.06 | -2.35K | n/a | n/a | n/a | n/a | n/a | -28K | n/a | n/a |
| Investing Cash Flow | -4.07M | 4.28M | -702K | -425K | -924K | -580K | -312K | -121K | -2.54M | -1.32M | -1.23M | -137K |
| Debt Repayment | -1.58M | -2.63M | -45.05M | 26.84M | 13.77M | 1.46M | 1.4M | 951K | 355K | 1.61M | 1.63M | 3.33M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 223K | 354K | 34K | 1.52M | 735K | 193K | 870K | 4K | 2K | 14K | n/a | n/a |
| Financial Cash Flow | 70.28M | -2.27M | -30.89M | 136.83M | 14.5M | 50.2M | 88.65M | 26.64M | 357K | 1.62M | 119.88M | 6.35M |
| Net Cash Flow | 30.48M | 24.15M | -92.75M | 111.69M | -36.11M | 6.37M | 57.48M | -11.1M | -35.66M | -17.87M | 108.61M | 3.88M |
| Free Cash Flow | -37.81M | 20.18M | -69.22M | -26.5M | -47.98M | -44.55M | -30.99M | -35.07M | -36.76M | -25.56M | -15.69M | -2.47M |